San Francisco — February 2, 2022 — Phizzle, the leader in digitizing and automating multi-vendor scientific lab instruments used in pharmaceutical manufacturing and other clean environments, today announced three industry thought leaders have joined its advisory board.
"We are humbled to have advisors who collectively bring decades of pharmaceutical industry expertise — and who have already helped us immensely as we prepare to scale our opportunity. The highly regulated nature of pharmaceutical manufacturing demands a rigorous understanding of process and procedure — we couldn't be more thankful to have Lena, Joi, and Guillermo on our team." — Ben Davis, CEO of Phizzle
The advisors include:
Lena Wu, Ph.D.
Independent Director for Matterworks, Inc., developing tools for biomanufacturing. Former co-founder and CEO of Intabio, Inc., which developed analytical systems for biomanufacturing and was acquired by SCIEX. Previously CEO and co-founder of Rogne Biosciences, a biotherapeutic company. Lena brings 25+ years of corporate development experience in early stage life science companies and received her Ph.D. in Molecular Pharmacology from Stanford School of Medicine.
Joi True
A seasoned life sciences professional with 25+ years of experience advising and partnering with research, early and late-stage development, commercial, medical affairs, and business development functions at all management levels to identify and resolve issues and meet company goals. Joi received an MBA from U.C. Berkeley in 2008 and a JD from U.C. Berkeley in 1993.
Guillermo Ardon
Investor and former senior executive at Johnson & Johnson, including serving as Chief Applications Officer & Company Vice President for J&J Enterprise, Group CIO of Supply Chain and Vice President, and CTO and Vice President of Infrastructure Services. Previously held the posts of Global Director of IT Operations and Director of IT Infrastructure in Asia and South America at Ford Motor Company. A graduate of The University of Arizona.
About Phizzle's EDGMaker Platform
Phizzle's EDGMaker is the world's first and only scientific instrument platform to centrally manage drug production data. Our technology is unlocking the manufacturing potential of the pharmaceutical industry by bringing data standardization, instrument automation, and FDA-compliant digital record-keeping to critical drug production.